A multicenter, double-blind, randomized, placebo-controlled study to determine the effect of montelukast sodium as an episode modifier in the treatment of infrequent episodic asthma in children

Trial Profile

A multicenter, double-blind, randomized, placebo-controlled study to determine the effect of montelukast sodium as an episode modifier in the treatment of infrequent episodic asthma in children

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Apr 2017

At a glance

  • Drugs Montelukast (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms PRE-EMPT
  • Sponsors Merck & Co
  • Most Recent Events

    • 29 Mar 2007 Status change
    • 15 Feb 2007 Results data have been published.
    • 26 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top